Predictors of substance use disorder treatment initiation and engagement among adolescents enrolled in Medicaid

References

• Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2020. PEP20-07-01-001.
   Google Scholar
• Maggs JL, Staff J, Kloska DD, Patrick ME, O'Malley PM, Schulenberg J. Predicting young adult degree attainment by late adolescent marijuana use. J Adolesc Health 2015;57(2):1260–211.
   Google Scholar
• Brewer RD, Swahn MH. Binge drinking and violence. JAMA 2005;294(5):616–618.
   PubMed Web of Science ®Google Scholar
• Bossarte RM, Swahn MH. The associations between early alcohol use and suicide attempts among adolescents with a history of major depression. Addict Behav. 2011;36(5):532–535.
   PubMedGoogle Scholar
• McManama O'Brien KH, Becker SJ, Spirito A, Simon V, Prinstein MJ. Differentiating adolescent suicide attempters from ideators: examining the interaction between depression severity and alcohol use. Suicide Life Threat Behav. 2014;44(1):23–33.
   PubMed Web of Science ®Google Scholar
• Chou R, Blazina DT, Grusing S, Fu R, Bougatsos C. Interventions for Drug Use—Supplemental Report: A Systematic Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 187. AHRQ Publication No. 19-05255-EF-2. Rockville, MD: Agency for Healthcare Research and Quality; 2020.
   Google Scholar
• Saloner B, Carson N, Le Cook B. Explaining racial/ethnic differences in adolescent substance abuse treatment completion in the United States: a decomposition analysis. J Adolesc Health 2014;54(6):646–653.
   PubMed Web of Science ®Google Scholar
• National Committee on Quality Assurance. HEDIS and Performance Measurement. https://www.ncqa.org/hedis/. Accessed October 1, 2021.
   Google Scholar
• National Committee on Quality Assurance. Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment (IET); 2021. https://www.ncqa.org/hedis/measures/initiation-and-engagement-of-alcohol-and-other-drug-abuse-or-dependence-treatment/. Accessed July 24, 2021.
   Google Scholar
• Garnick DW, Horgan CM, Chalk M. Performance measures for alcohol and other drug services. Alcohol Res Health 2006;29(1):19–26.
   PubMedGoogle Scholar
• Watkins KE, Paddock SM, Hudson TJ, et al. Association between quality measures and mortality in individuals with co-occurring mental health and substance use disorders. J Subst Abuse Treat. 2016;69:1–8.
   PubMed Web of Science ®Google Scholar
• Lind BK, McCarty D, Gu Y, Baker R, John McConnell K. Predictors of substance use treatment initiation and engagement among adult and adolescent Medicaid recipients. Subst Abuse 2019;40(3):285–291.
   PubMed Web of Science ®Google Scholar
• Binswanger IA, Carroll NM, Ahmedani BK, et al. The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders. Subst Abuse 2019;40(3):292–301.
   PubMed Web of Science ®Google Scholar
• Lapham GT, Campbell CI, Yarborough BJH, et al. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems. Subst Abuse 2019;40(3):268–277.
   PubMed Web of Science ®Google Scholar
• Weisner C, Campbell CI, Altschuler A, et al. Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014–2015. Subst Abuse 2019;40(3):318–327.
   PubMed Web of Science ®Google Scholar
• Acevedo A, Garnick DW, Lee MT, et al. Racial and ethnic differences in substance abuse treatment initiation and engagement. J Ethn Subst Abuse 2012;11(1):1–21.
   PubMedGoogle Scholar
• Garnick DW, Lee MT, O'Brien PL, et al. The Washington circle engagement performance measures' association with adolescent treatment outcomes. Drug Alcohol Depend. 2012;124(3):250–258.
   PubMed Web of Science ®Google Scholar
• Lee MT, Garnick DW, O'Brien PL, et al. Adolescent treatment initiation and engagement in an evidence-based practice initiative. J Subst Abuse Treat. 2012;42(4):346–355.
   PubMedGoogle Scholar
• Lee MT, Garnick DW, Horgan CM, Cavanaugh DA. Constructing adolescent substance abuse performance measures using administrative data. J Healthc Qual. 2006;28(3):42–48. 59.
   PubMedGoogle Scholar
• Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D. Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr. 2014;14:199.
   PubMed Web of Science ®Google Scholar
• Doupnik S, Rodean J, Zima BT, et al. Readmissions after pediatric hospitalization for suicide ideation and suicide attempt. J Hosp Med. 2018;13(11):743–751.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. HCUP Chronic Condition Indicator (CCI) for ICD-9-CM. https://www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp. Accessed April 29, 2021.
   Google Scholar
• Fontanella CA, Warner LA, Steelesmith DL, Brock G, Bridge JA, Campo JV. Association of timely outpatient mental health services for youths after psychiatric hospitalization with risk of death by suicide. JAMA Netw Open 2020;3(8):e2012887.
   PubMed Web of Science ®Google Scholar
• MHResearchNetwork. Public Resources from the Mental Health Research Network. https://github.com/MHResearchNetwork/MHRN-Central. Accessed April 1, 2021.
   Google Scholar
• Alegria M, Frank RG, Hansen HB, Sharfstein JM, Shim RS, Tierney M. Transforming mental health and addiction services. Health Aff. 2021;40(2):226–234.
   PubMed Web of Science ®Google Scholar
• Libby AM, Riggs PD. Integrated substance use and mental health treatment for adolescents: aligning organizational and financial incentives. J Child Adolesc Psychopharmacol. 2005;15(5):826–834.
   PubMedGoogle Scholar
• Pitts B, Aalsma MC, Brooks M, et al. Improving integration of behavioral health into primary care for adolescents and young adults. J Adolesc Health 2020;67(2):302–306.
   PubMedGoogle Scholar
• Hawkins EH. A tale of two systems: co-occurring mental health and substance abuse disorders treatment for adolescents. Annu Rev Psychol. 2009;60:197–227.
   PubMed Web of Science ®Google Scholar
• Loree AM, Yeh HH, Satre DD, et al. Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems. Subst Abuse 2019;40(3):311–317.
   PubMed Web of Science ®Google Scholar
• Gaither JR, Leventhal JM, Ryan SA, Camenga DR. National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. JAMA Pediatr. 2016;170(12):1195–1201.
   PubMed Web of Science ®Google Scholar
• Gaither JR, Shabanova V, Leventhal JM. US national trends in pediatric deaths from prescription and illicit opioids, 1999–2016. JAMA Netw Open 2018;1(8):e186558.
   PubMed Web of Science ®Google Scholar
• Miron O, Yu KH, Wilf-Miron R, Kohane IS. Suicide rates among adolescents and young adults in the United States, 2000–2017. JAMA 2019;321(23):2362–2364.
   PubMed Web of Science ®Google Scholar
• Watkins KE, Paddock SM, Hudson TJ, et al. Association between process measures and mortality in individuals with opioid use disorders. Drug Alcohol Depend. 2017;177:307–314.
   PubMedGoogle Scholar
• Mattke S, Predmore Z, Sloss E, Wilks A, Watkins KE. Evidence for misspecification of a nationally used quality measure for substance use treatment. J Healthc Qual. 2018;40(4):228–235.
   PubMed Web of Science ®Google Scholar
• Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. 2017;171(8):747–755.
   PubMed Web of Science ®Google Scholar
• Hadland SE, Bagley SM, Rodean J, et al. Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder. JAMA Pediatr. 2018;172(11):1029–1037.
   PubMed Web of Science ®Google Scholar
• Chavez LJ, Bonny AE, Bradley KA, et al. Medication treatment and health care use among adolescents with opioid use disorder in Ohio. The Journal of Adolescent Health. 2020;67(1):33–39.
   PubMed Web of Science ®Google Scholar
• Beyers JM, Toumbourou JW, Catalano RF, Arthur MW, Hawkins JD. A cross-national comparison of risk and protective factors for adolescent substance use: the United States and Australia. The Journal of Adolescent Health 2004;35(1):3–16.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Projections of National Expenditures for Treatment of Mental and Substance Use Disorders, 2010–2020. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. HHS Publication No. SMA-14-4883.
   Google Scholar